1. Building: 800 Research Parkway Building 1, Oklahoma City, OK 2. Amended Lease Premises: The Leased Premises will change to include all of the 1st floor consisting of approximately 22,833 rentable square feet (RSF) and all of the 2nd floor...
Lease Agreement • October 13th, 1999 • Zymetx Inc • In vitro & in vivo diagnostic substances
Contract Type
Filed
October 13th, 1999
Company
Industry

See All (1k)

1 AMENDMENT NO. 1 TO
Executive Services Agreement • October 13th, 1999 • Zymetx Inc • In vitro & in vivo diagnostic substances
Contract Type
Filed
October 13th, 1999
Company
Industry

See All (26)

1 ANNEX "B" SEVERANCE COMPENSATION AGREEMENT SEVERANCE COMPENSATION AGREEMENT (the "Agreement") dated as of April 14, 1999, by and between ZymeTx, Inc., a Delaware corporation (the "Company"), and Peter G. Livingston (the "Executive"). WHEREAS, the...
Severance Compensation Agreement • October 13th, 1999 • Zymetx Inc • In vitro & in vivo diagnostic substances • Oklahoma
Contract Type
Filed
October 13th, 1999
Company
Industry
Jurisdiction

See All (8)

1 SEVERANCE COMPENSATION AGREEMENT SEVERANCE COMPENSATION AGREEMENT (the "Agreement") dated as of April 14, 1999, by and between ZymeTx, Inc., a Delaware corporation (the "Company"), and Gary W. Pedersen (the "Executive"). WHEREAS, the Company's Board...
Severance Compensation Agreement • October 13th, 1999 • Zymetx Inc • In vitro & in vivo diagnostic substances • Oklahoma
Contract Type
Filed
October 13th, 1999
Company
Industry
Jurisdiction

See All (6)

0000950134-99-008885 Sample Contracts

Filter & Search